Evidence map›Paper›PMID 35838183›Full record

ArticleCancer communications (London, England)2022

Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells.

Jang Hee Han, Yong Keon Kim, Hakhyun Kim, Jooyoung Lee, Myung Joon Oh, Sang Bum Kim, Minjee Kim, Kook Hwan Kim, Hyun Ju Yoon, Myung-Shik Lee and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cancer communications (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Precision immune regulation in KRAS-mutated cancers: the final piece of the puzzle?Journal of experimental & clinical cancer research : CR · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 3 countries.

Jang Hee HanSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
Yong Keon KimSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
Hakhyun KimSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
Jooyoung LeeSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
Myung Joon OhSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
Sang Bum KimSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
Minjee KimSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
Kook Hwan KimSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
Hyun Ju YoonSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
Myung-Shik LeeSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.
John D MinnaHamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
Michael A WhiteDepartment of Cell Biology, University of Texas Southwestern Medical Center, Dallas, Texas, 75390, USA.
Hyun Seok KimSeverance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, 03722, Korea.ORCID 0000-0003-4498-8690
Yonsei University · KRSouthwestern Medical Center

Funding

UNIVERSITY OF TEXAS--SPORE IN LUNG CANCERP50CA070907 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI HEYMACH, JOHN V., MINNA, JOHN D. · 1996 to 2024
$57.4M
NCI NIH HHS P50 CA070907
6 · The paper itself

Abstract

backgroundAutophagy is elevated in metastatic tumors and is often associated with active epithelial-to-mesenchymal transition (EMT). However, the extent to which EMT is dependent on autophagy is largely unknown. This study aimed to identify the mechanisms by which autophagy facilitates EMT.

methodsWe employed a liquid chromatography-based metabolomic approach with kirsten rat sarcoma viral oncogene (KRAS) and liver kinase B1 (LKB1) gene co-mutated (KL) cells that represent an autophagy/EMT-coactivated invasive lung cancer subtype for the identification of metabolites linked to autophagy-driven EMT activation. Molecular mechanisms of autophagy-driven EMT activation were further investigated by quantitative real-time polymerase chain reaction (qRT-PCR), Western blotting analysis, immunoprecipitation, immunofluorescence staining, and metabolite assays. The effects of chemical and genetic perturbations on autophagic flux were assessed by two orthogonal approaches: microtubule-associated protein 1A/1B-light chain 3 (LC3) turnover analysis by Western blotting and monomeric red fluorescent protein-green fluorescent protein (mRFP-GFP)-LC3 tandem fluorescent protein quenching assay. Transcription factor EB (TFEB) activity was measured by coordinated lysosomal expression and regulation (CLEAR) motif-driven luciferase reporter assay. Experimental metastasis (tail vein injection) mouse models were used to evaluate the impact of calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) or ATP citrate lyase (ACLY) inhibitors on lung metastasis using IVIS luciferase imaging system.

resultsWe found that autophagy in KL cancer cells increased acetyl-coenzyme A (acetyl-CoA), which facilitated the acetylation and stabilization of the EMT-inducing transcription factor Snail. The autophagy/acetyl-CoA/acetyl-Snail axis was further validated in tumor tissues and in autophagy-activated pancreatic cancer cells. TFEB acetylation in KL cancer cells sustained pro-metastatic autophagy in a mammalian target of rapamycin complex 1 (mTORC1)-independent manner. Pharmacological inhibition of this axis via CAMKK2 inhibitors or ACLY inhibitors consistently reduced the metastatic capacity of KL cancer cells in vivo.

conclusionsThis study demonstrates that autophagy-derived acetyl-CoA promotes Snail acetylation and thereby facilitates invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells and that inhibition of the autophagy/acetyl-CoA/acetyl-Snail axis using CAMKK2 or ACLY inhibitors could be a potential therapeutic strategy to suppress metastasis of KL lung cancer.

Indexed as

Lung NeoplasmsProto-Oncogene Proteins p21(ras)AcetylationAcetyl Coenzyme AAMP-Activated Protein KinasesAnimalsAutophagyMammalsMiceNeoplastic ProcessesSnail Family Transcription FactorsTranscription FactorsAcetyl Coenzyme AAMP-Activated Protein KinasesProto-Oncogene Proteins p21(ras)Snail Family Transcription FactorsStk11 protein, mouseTranscription Factorsacetyl-coenzyme Aacetyl-snailACLYautophagyCAMKK2epithelial-to-mesenchymal transitionKRAS inhibitormetastasisnon-small-cell lung cancerpancreatic cancersnail

Identifiers

PMID35838183
PMCPMC9395322
OpenAlexW4285590279

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.